4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001209191-21-069422
Chief Medical Officer acquired 22,307 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Farwell Wildon Chief Medical Officer | 2021-12-10 | Grant or award | +22,307 | 72,307 | D | ||
| Derivatives | |||||||
| Farwell Wildon Chief Medical Officer | 2021-12-10 | Grant or award · Stock Option (right to buy) | +67,935 | 67,935 | D | ||
Loading xslF345X03/doc4.xml…